Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

Promising new agent for urinary incontinence discovered by Kyorin

Nov. 6, 2003

Uroxatral launched in U.S.

Nov. 5, 2003

Positive results reported from phase IIb study of PT-141

Nov. 5, 2003

SK-3530, a potent and selective PDE5 inhibitor in clinical testing for MED

Oct. 31, 2003

Novel phosphate transport inhibitors discovered at Genzyme

Oct. 31, 2003

Kyowa Hakko presents urethra-selective agents for urinary incontinence therapy

Oct. 28, 2003

Keryx initiates phase II/III program of KRX-101 for diabetic nephropathy

Oct. 23, 2003

New sGC activators for erectile dysfunction claimed by Abbott researchers

Oct. 23, 2003

Yamanouchi receives approvable letter for Vesicare

Oct. 21, 2003

Vasopressin V2 receptor antagonist effective in early and established polycystic kidney disease

Oct. 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...